Published in Cancer Med on May 07, 2014
Signatures of mutation and selection in the cancer genome. Nature (2010) 9.75
One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst (1977) 6.91
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene (2006) 5.86
Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice. Nat Genet (1996) 3.42
U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line. PLoS Genet (2010) 2.99
Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia (2005) 2.62
Recent advances in cancer stem cells. Curr Opin Genet Dev (2008) 2.17
Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int J Cancer (2008) 2.11
Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res (1987) 2.03
Characterization of stem cell attributes in human osteosarcoma cell lines. Cancer Biol Ther (2009) 1.83
Human interferon: mass production in a newly established cell line, MG-63. Antimicrob Agents Chemother (1977) 1.79
CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. Cancer Res (2010) 1.78
Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells (2006) 1.78
Mobilization and activation of a signaling competent alpha6beta4integrin underlies its contribution to carcinoma progression. Cancer Metastasis Rev (2005) 1.58
Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name? Biochem Biophys Res Commun (2007) 1.57
Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression. Proc Natl Acad Sci U S A (2008) 1.54
Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells. J Bone Miner Res (1999) 1.52
Targeting the osteosarcoma cancer stem cell. J Orthop Surg Res (2010) 1.52
Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort. Genes Chromosomes Cancer (2010) 1.50
Mutant p53 cooperates with ETS2 to promote etoposide resistance. Genes Dev (2012) 1.47
Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma. Cancer Res (2009) 1.46
CD49f enhances multipotency and maintains stemness through the direct regulation of OCT4 and SOX2. Stem Cells (2012) 1.40
A homozygous mutation in the integrin alpha6 gene in junctional epidermolysis bullosa with pyloric atresia. J Clin Invest (1997) 1.35
Functional characterization of osteosarcoma cell lines provides representative models to study the human disease. Lab Invest (2011) 1.32
Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. Exp Cell Res (2004) 1.16
Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy. Rev Recent Clin Trials (2008) 1.16
Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture. Cancer Res (1972) 1.09
Osteosarcoma: time to move on? Eur J Cancer (2010) 1.04
Strategies for the targeted delivery of therapeutics for osteosarcoma. Expert Opin Drug Deliv (2009) 1.02
Differentiation and characterization of human MSCs. Methods Mol Biol (2008) 0.95
SIGNATURE: a workbench for gene expression signature analysis. BMC Bioinformatics (2011) 0.94
Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium. BMC Genomics (2007) 0.93
Derivation and characterization of an extra-axial chordoma cell line (EACH-1) from a scapular tumor. J Bone Joint Surg Am (2010) 0.92
A critical role of CD29 and CD49f in mediating metastasis for cancer-initiating cells isolated from a Brca1-associated mouse model of breast cancer. Oncogene (2013) 0.88
CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate. PLoS One (2012) 0.87
Enrichment of osteosarcoma stem cells by chemotherapy. Chin J Cancer (2011) 0.84
Osteosarcoma: clinical practice and the expanding role of biology. J Musculoskelet Neuronal Interact (2002) 0.84
Histamine receptor H1 and dermatopontin: new downstream targets of the vitamin D receptor. J Bone Miner Res (2007) 0.82
Human sarcoma cell lines MES-SA and MES-SA/Dx5 as a model for multidrug resistance modulators screening. Anticancer Res (2005) 0.82
Alpha6-integrin is expressed on germinal centre B cells and modifies growth of a B-cell line. Immunology (2004) 0.81
Establishment and characterization of cell lines derived from a human osteosarcoma. Clin Orthop Relat Res (1985) 0.81
Making gene therapy for osteosarcoma a reality. Expert Rev Anticancer Ther (2010) 0.81
CD49f(high) cells retain sphere-forming and tumor-initiating activities in human gastric tumors. PLoS One (2013) 0.79
GFP expression alters osteosarcoma cell biology. DNA Cell Biol (2007) 0.78
Methods for determining the proliferation of cells in response to EGFR ligands. Methods Mol Biol (2006) 0.78
Isolation of stem-like cells from human MG-63 osteosarcoma cells using limiting dilution in combination with vincristine selection. Indian J Biochem Biophys (2010) 0.77
Reversion of Kirsten sarcoma virus transformed human cells: elimination of the sarcoma virus nucleotide sequences. J Gen Virol (1979) 0.76
Regulation of cancer cell migration and bone metastasis by RANKL. Nature (2006) 5.27
Progesterone induces adult mammary stem cell expansion. Nature (2010) 4.69
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature (2010) 4.01
Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet (2004) 2.96
The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.71
RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev (2005) 2.59
Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res (2008) 2.19
iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science (2012) 2.14
Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol (2003) 2.12
Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS One (2007) 2.06
Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells (2007) 2.05
Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation (2007) 2.03
Involvement of mammalian Mus81 in genome integrity and tumor suppression. Science (2004) 2.03
CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. Cancer Res (2010) 1.78
Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3. Cardiovasc Res (2005) 1.77
Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J Clin Invest (2005) 1.76
Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice. J Clin Invest (2010) 1.75
Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. Immunity (2012) 1.75
Somatic expression of LINE-1 elements in human tissues. Nucleic Acids Res (2010) 1.61
Virus subversion of the MHC class I peptide-loading complex. Immunity (2003) 1.60
ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site. J Cell Sci (2010) 1.49
Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol (2006) 1.45
Pelvic fractures in women of childbearing age. Clin Orthop Relat Res (2010) 1.44
Identifying Hendra virus diversity in pteropid bats. PLoS One (2011) 1.40
Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res (2007) 1.40
Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus. Reproduction (2007) 1.37
TIMP-3 deficiency leads to dilated cardiomyopathy. Circulation (2004) 1.36
Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology (2008) 1.36
Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol (2006) 1.35
Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice. J Clin Invest (2010) 1.35
Individual Timp deficiencies differentially impact pro-MMP-2 activation. J Biol Chem (2006) 1.34
Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases. FASEB J (2008) 1.32
Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology (2005) 1.31
BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival. J Exp Med (2013) 1.30
Novel, potentially zoonotic paramyxoviruses from the African straw-colored fruit bat Eidolon helvum. J Virol (2012) 1.30
The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis. Crit Rev Clin Lab Sci (2008) 1.28
Utilization of lymphoblastoid cell lines as a system for the molecular modeling of autism. J Autism Dev Disord (2006) 1.26
Clipping, shedding and RIPping keep immunity on cue. Trends Immunol (2008) 1.20
Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinoma. Oncogene (2003) 1.20
Collaboration of Brca1 and Chk2 in tumorigenesis. Genes Dev (2004) 1.18
Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents. Diabetes (2010) 1.17
Synthesis of enantioenriched triarylmethanes by stereospecific cross-coupling reactions. Angew Chem Int Ed Engl (2012) 1.17
Linking DNA replication checkpoint to MBF cell-cycle transcription reveals a distinct class of G1/S genes. EMBO J (2012) 1.16
Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice. Arthritis Rheum (2007) 1.16
Structural genomics analysis of alternative splicing and application to isoform structure modeling. Proc Natl Acad Sci U S A (2005) 1.15
Model for the interaction of gammaherpesvirus 68 RING-CH finger protein mK3 with major histocompatibility complex class I and the peptide-loading complex. J Virol (2004) 1.14
Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. J Cell Sci (2012) 1.13
Myocardial extra-cellular matrix and its regulation by metalloproteinases and their inhibitors. Thromb Haemost (2005) 1.12
Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells. Development (2013) 1.11
Activation of autophagy in mesenchymal stem cells provides tumor stromal support. Carcinogenesis (2011) 1.10
Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury. Am J Pathol (2009) 1.10
Simultaneous transforming growth factor beta-tumor necrosis factor activation and cross-talk cause aberrant remodeling response and myocardial fibrosis in Timp3-deficient heart. J Biol Chem (2009) 1.10
Thinking outside the cell: proteases regulate hepatocyte division. Trends Cell Biol (2005) 1.08
Notch and Mef2 synergize to promote proliferation and metastasis through JNK signal activation in Drosophila. EMBO J (2012) 1.05
fMRI study of language activation in schizophrenia, schizoaffective disorder and in individuals genetically at high risk. Schizophr Res (2007) 1.05
Physical association of the K3 protein of gamma-2 herpesvirus 68 with major histocompatibility complex class I molecules with impaired peptide and beta(2)-microglobulin assembly. J Virol (2002) 1.05
Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine (2011) 1.05
A null mutation for tissue inhibitor of metalloproteinases-3 (Timp-3) impairs murine bronchiole branching morphogenesis. Dev Biol (2003) 1.04
Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice. Hepatology (2010) 1.03
Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. Cancer Res (2002) 1.02
Antibodies to henipavirus or henipa-like viruses in domestic pigs in Ghana, West Africa. PLoS One (2011) 1.02
Role of gene expression microarray analysis in finding complex disease genes. Genet Epidemiol (2002) 1.02
Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload. J Biol Chem (2010) 1.02
Inflammation and breast cancer: metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer. Breast Cancer Res (2008) 0.99
The combined effect of encapsulating curcumin and C6 ceramide in liposomal nanoparticles against osteosarcoma. Mol Pharm (2014) 0.98
Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis. Am J Pathol (2005) 0.98
Insulin-like growth factor-II regulates PTEN expression in the mammary gland. J Biol Chem (2003) 0.98
Vaccine potential of Nipah virus-like particles. PLoS One (2011) 0.97
TIMP-3 recruits quiescent hematopoietic stem cells into active cell cycle and expands multipotent progenitor pool. Blood (2010) 0.97
Biochemical, conformational, and immunogenic analysis of soluble trimeric forms of henipavirus fusion glycoproteins. J Virol (2012) 0.96
Bizarre parosteal osteochondromatous proliferation of the proximal humerus: case report. Skeletal Radiol (2007) 0.95
Cbl-3-deficient mice exhibit normal epithelial development. Mol Cell Biol (2003) 0.95
Resveratrol and prostate cancer: promising role for microRNAs. Mol Nutr Food Res (2011) 0.93
Epigenetic reprogramming of IGF1 and leptin genes by serum deprivation in multipotential mesenchymal stromal cells. Stem Cells (2009) 0.92
Derivation and characterization of an extra-axial chordoma cell line (EACH-1) from a scapular tumor. J Bone Joint Surg Am (2010) 0.92
Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantation. Biol Blood Marrow Transplant (2010) 0.91
Proteolytic factors in exosomes. Proteomics (2013) 0.90
Evaluation of microarray-based DNA methylation measurement using technical replicates: the Atherosclerosis Risk In Communities (ARIC) Study. BMC Bioinformatics (2014) 0.90
Requirements for the selective degradation of endoplasmic reticulum-resident major histocompatibility complex class I proteins by the viral immune evasion molecule mK3. J Virol (2005) 0.90
Unraveling metalloproteinase function in skeletal biology and disease using genetically altered mice. Biochim Biophys Acta (2009) 0.90
The checkpoint transcriptional response: make sure to turn it off once you are satisfied. Cell Cycle (2012) 0.89
Chondromyxoid fibroma of the radial shaft treated with nonvascularized fibular autograft. Am J Orthop (Belle Mead NJ) (2010) 0.89
Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis (2016) 0.88
A method of predicting changes in human gene splicing induced by genetic variants in context of cis-acting elements. BMC Bioinformatics (2010) 0.88
Analysis of Patterns of Gene Expression Variation within and between Ethnic Populations in Pediatric B-ALL. Cancer Inform (2013) 0.88
Use of differentiating adult stem cells (marrow stromal cells) to identify new downstream target genes for transcription factors. Stem Cells (2006) 0.87
Cardiac extracellular proteome profiling and membrane topology analysis using glycoproteomics. Proteomics Clin Appl (2014) 0.86
Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay. EMBO Mol Med (2013) 0.85
Proteolysis during tumor cell extravasation in vitro: metalloproteinase involvement across tumor cell types. PLoS One (2013) 0.85
Active allies: hormones, stem cells and the niche in adult mammopoiesis. Trends Endocrinol Metab (2012) 0.85
Metalloproteinase axes increase beta-catenin signaling in primary mouse mammary epithelial cells lacking TIMP3. J Cell Sci (2007) 0.85
Neither ovariectomy nor progestin treatment prevents endometrial neoplasia in pten+/- mice. Gynecol Oncol (2007) 0.85
Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis. J Gene Med (2004) 0.85
Nipah virus in the fruit bat Pteropus vampyrus in Sumatera, Indonesia. PLoS One (2013) 0.85
Increased neovascularization in mice lacking tissue inhibitor of metalloproteinases-3. Invest Ophthalmol Vis Sci (2011) 0.84